Cambiar Investors LLC Sells 135,838 Shares of Waters Co. (NYSE:WAT)

Cambiar Investors LLC lowered its holdings in shares of Waters Co. (NYSE:WAT) by 81.3% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 31,168 shares of the medical instruments supplier’s stock after selling 135,838 shares during the period. Cambiar Investors LLC’s holdings in Waters were worth $11,563,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Kennebec Savings Bank bought a new position in Waters during the third quarter worth about $33,000. Fortitude Family Office LLC grew its holdings in Waters by 235.7% during the fourth quarter. Fortitude Family Office LLC now owns 94 shares of the medical instruments supplier’s stock worth $35,000 after purchasing an additional 66 shares during the period. Ashton Thomas Securities LLC bought a new position in Waters during the third quarter worth about $35,000. R Squared Ltd bought a new position in Waters during the fourth quarter worth about $63,000. Finally, Itau Unibanco Holding S.A. grew its holdings in Waters by 63.2% during the third quarter. Itau Unibanco Holding S.A. now owns 186 shares of the medical instruments supplier’s stock worth $67,000 after purchasing an additional 72 shares during the period. Institutional investors own 94.01% of the company’s stock.

Wall Street Analyst Weigh In

WAT has been the subject of a number of research analyst reports. Wells Fargo & Company lifted their price target on Waters from $380.00 to $415.00 and gave the stock an “overweight” rating in a report on Monday, November 4th. Cfra set a $389.00 price objective on shares of Waters in a research report on Thursday, October 17th. JPMorgan Chase & Co. raised their price objective on shares of Waters from $340.00 to $380.00 and gave the stock a “neutral” rating in a research report on Monday, November 4th. Deutsche Bank Aktiengesellschaft raised their price objective on shares of Waters from $310.00 to $325.00 and gave the stock a “hold” rating in a research report on Monday, November 4th. Finally, Stifel Nicolaus raised their price objective on shares of Waters from $332.00 to $360.00 and gave the stock a “hold” rating in a research report on Monday, November 4th. Ten analysts have rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $388.64.

Waters Stock Down 0.5 %

NYSE WAT opened at $407.61 on Tuesday. The company has a current ratio of 2.02, a quick ratio of 1.38 and a debt-to-equity ratio of 1.14. Waters Co. has a 1-year low of $279.24 and a 1-year high of $423.56. The company has a 50 day moving average of $389.98 and a 200-day moving average of $363.11. The company has a market cap of $24.20 billion, a price-to-earnings ratio of 38.89, a PEG ratio of 7.37 and a beta of 1.01.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.